Skip to main content
. Author manuscript; available in PMC: 2018 Mar 15.
Published in final edited form as: Clin Cancer Res. 2017 Jun 14;23(18):5366–5373. doi: 10.1158/1078-0432.CCR-17-0645

Table 1.

Clinical characteristics

All (N=15) High amp (N=7) Low amp (N=8)
Age
 Median 66 67 66
 Range 48–72 48–73 55–72
Sex
 Female 6 (40%) 4 (57%) 2 (25%)
Race
 White 11 (73%) 7 (100%) 4 (50%)
WHO performance status
 Restricted activity 10 (67%) 4 (57%) 6 (75%)
Prior lines of therapy
 Median (range) 3 (1–7) 2 (1–5) 3 (2–7)
 Prior treatment with first-line platinum doublet 100% 100% 100%
Histology
 Squamous cell carcinoma 100% 100% 100%
HHS Vulnerability Disclosure